The effects of a single dialysis session on serum hepcidin levels
Author:
Oğuzman Hamdi1ORCID, Kın Tekçe Buket2ORCID, Tekçe Hikmet3ORCID, Buğdaycı Güler4ORCID
Affiliation:
1. Department of Medical Biochemistry, Faculty of Medicine , Hatay Mustafa Kemal University , Hatay , Türkiye 2. Department of Medical Biochemistry, Faculty of Medicine , Bolu Abant İzzet Baysal University , Bolu , Türkiye 3. Department of Nephrology, Faculty of Medicine , Bolu Abant İzzet Baysal University , Bolu , Türkiye 4. Department of Medical Biochemistry, Faculty of Medicine , Halic University , İstanbul , Türkiye
Abstract
Abstract
Objectives
Hepcidin plays an important role in regulating iron metabolism. Elevated levels of hepcidin in renal failure contribute to the development of anemia. We aimed to evaluate the association between hepcidin and inflammation in hemodialysis patients and how dialysis affects hepcidin levels.
Methods
Hepcidin clearance with hemodialysis was investigated by measuring hepcidin concentrations by enzyme-linked immunosorbent assay (ELISA) method before and after hemodialysis of 40 patients in a single dialysis session. Hemogram parameters and ferritin, iron, total iron binding capacity (TIBC), and C-reactive protein (CRP) were measured and evaluated their relations with predialysis hepcidin levels.
Results
Hepcidin levels decreased significantly with dialysis treatment (p=0.009). Median hepcidin concentration before dialysis was measured as 330 ng/mL (83–459) and post-dialysis median hepcidin concentration was 250 ng/mL (94–384). There was a significant correlation between predialysis hepcidin levels and ferritin (r=0.858, p<0.001), TIBC (r=−0.451, p=0.004), and MCV (r=0.384, p=0.016). It was found that increases in ferritin levels in time were positively correlated with hepcidin before dialysis.
Conclusions
We think that understanding the removal of the hepcidin by dialysis, which causes a decrease in the amount of iron available in the anemia, is important in managing future therapy.
Funder
Abant Izzet Baysal Ãœniversitesi
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,Molecular Biology,Biochemistry
Reference38 articles.
1. Gafter-Gvili, A, Schechter, A, Rozen-Zvi, B. Iron deficiency anemia in chronic kidney disease. Acta Haematol 2019;142:44–50. https://doi.org/10.1159/000496492. 2. Yu, ASL, Chertow, GM, Luyckx, VA, Marsden, PA, Skorecki, K, Taal, MW, et al.. Brenner and Rector’s the Kidney 2-Volume Set e-Book, 11th ed. Philadelphia, PA: Elsevier; 2020:1861 p. 3. Abuşoğlu, S, Aydın, İ, Bakar, F, Bekdemir, T, Gülbahar, Ö, İşlekel, H, et al.. A short guideline on chronic kidney disease for medical laboratory practice/Kronik böbrek hastalığında tıbbi laboratuvar uygulamaları için kısa kılavuz. Turk J Biochem 2016;41:292–301. https://doi.org/10.1515/tjb-2016-0043. 4. Hall, JE, Hall, ME. Guyton and Hall textbook of Medical physiology e-Book, 14th ed. Philadelphia, PA: Elsevier; 2021:443 p. 5. Kroot, JJ, Tjalsma, H, Fleming, RE, Swinkels, DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650–69. https://doi.org/10.1373/clinchem.2009.140053.
|
|